0001225208-22-003666.txt : 20220301
0001225208-22-003666.hdr.sgml : 20220301
20220301160302
ACCESSION NUMBER: 0001225208-22-003666
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220226
FILED AS OF DATE: 20220301
DATE AS OF CHANGE: 20220301
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: McDermott Michael
CENTRAL INDEX KEY: 0001902464
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-03619
FILM NUMBER: 22697858
MAIL ADDRESS:
STREET 1: C/O PFIZER INC. CORPORATE SECRETARY
STREET 2: 235 EAST 42ND STREET
CITY: 235 EAST 42ND STREET
STATE: NY
ZIP: 10017
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: PFIZER INC
CENTRAL INDEX KEY: 0000078003
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 135315170
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 235 E 42ND ST
CITY: NEW YORK
STATE: NY
ZIP: 10017
BUSINESS PHONE: 2125732323
MAIL ADDRESS:
STREET 1: 235 E 42ND ST
CITY: NEW YORK
STATE: NY
ZIP: 10017
FORMER COMPANY:
FORMER CONFORMED NAME: PFIZER CHARLES & CO INC
DATE OF NAME CHANGE: 19710908
4
1
doc4.xml
X0306
4
2022-02-26
0000078003
PFIZER INC
PFE
0001902464
McDermott Michael
PFIZER INC.-CORP. SECRETARY
235 EAST 42ND ST.
NEW YORK
NY
10017
1
Executive Vice President
Common Stock
2022-02-26
4
M
0
12340.0000
25.6000
A
83530.0000
D
Common Stock
2022-02-26
4
F
0
2372.0000
47.7200
D
81158.0000
D
Common Stock
2022-02-26
4
F
0
5761.0000
50.6400
D
75397.0000
D
Common Stock
2022-02-28
4
F
0
1384.0000
46.9400
D
74013.0000
D
Stock Appreciation Rights
25.6000
2022-02-26
4
M
0
12340.0000
0.0000
D
2022-02-26
2022-02-26
Common Stock
12340.0000
0.0000
D
The reported transaction constitutes the earn-out of stock appreciation rights (including dividend equivalents thereon).
The reported transaction constitutes the withholding of shares to satisfy tax obligations in connection with earn-out of stock appreciation rights.
Price is the closing price of Pfizer common stock on February 25, 2022.
The reported transaction constitutes the withholding of shares to cover payment of exercise price in connection with earn-out of stock appreciation rights (including dividend equivalents thereon).
Under the terms of the settlement of the stock appreciation rights the 20-day average of the closing prices of Pfizer common stock ending on the settlement date is used.
The reported transaction constitutes the withholding of shares to satisfy tax obligations upon the vesting of restricted stock units (including dividend equivalents thereon).
Susan E. Grant, by power of atty., for Michael McDermott
2022-03-01